Comparative effects of the antipsychotics sulpiride or risperidone in rats - I: Bodyweight, food intake, body composition, hormones and glucose tolerance

被引:89
作者
Baptista, T [1 ]
de Baptista, EA
Kin, NMKNY
Beaulieu, S
Walker, D
Joober, R
Lalonde, J
Richard, D
机构
[1] Univ Los Andes, Sch Med, Dept Physiol, Merida 5101A, Venezuela
[2] McGill Univ, Douglas Hosp, Res Ctr, Verdun, PQ H4H 1R3, Canada
[3] Univ Los Andes, Sch Med, Sch Pharm, Merida 5101A, Venezuela
[4] Univ Laval, Sch Med, Quebec City, PQ, Canada
关键词
antipsychotic drugs; glucose tolerance; leptin; rats; reproductive hormones; weight gain;
D O I
10.1016/S0006-8993(02)03616-8
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Obesity and related metabolic disorders are important side effects of some antipsychotic drugs (APs). The currently available animal model of AP-induced bodyweight gain (BWG) in rats is based on administration of sulpiride (SUL). However, this model has important limitations. For example, SUL is a pure dopamine antagonist, whereas most AN in current clinical use interact with multiple neurotransmitter receptors involved in food intake (FI) and metabolism regulation. Therefore, we evaluated the effects of risperidone (RIS, 0.125, 0.25 or 0.5 mg/kg during 16 days) on BWG and FI in male and female rats. Comparison between RIS (0.5 mg/kg), SUL (20 mg/kg) and vehicle (VEH) during 12 days was also conducted in females. In male rats, RIS did not significantly affect BWG, FI, glucose tolerance or leptin levels, even though prolactin and corticosterone were significantly elevated. In females, both APs significantly increased BWG and FI, but the effect was stronger with SUL. The BWG was significantly associated with an increase in body fat. Serum leptin levels were increased only in SUL-treated rats. The area under the curve for glucose (AUGC) was significantly lower in the SUL group, but it was similar for insulin in all treatment groups. The area under the curve for insulin (AUIC) and BWG positively correlated only in the RIS group. Prolactin and corticosterone were significantly increased by both APs. Serum estradiol levels were significantly increased by RIS but not by SUL, but progesterone levels were similar in both groups. The observed positive correlation between BWG and the AUIC during RIS administration suggests that this agent may represent a better model of AP administration in humans. The animal model of RIS-induced obesity in rats might be improved by testing other doses, route of administration and type of diet. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:144 / 151
页数:8
相关论文
共 51 条
  • [1] Allison DB, 1999, AM J PSYCHIAT, V156, P1686
  • [2] The antipsychotic drug sulpiride does not affect bodyweight in male rats.: Is insulin resistance involved?
    Baptista, T
    Lacruz, A
    Pàez, X
    Hernàndez, L
    Beaulieu, S
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2002, 447 (01) : 91 - 98
  • [3] SYSTEMIC SULPIRIDE INCREASES DOPAMINE METABOLITES IN THE LATERAL HYPOTHALAMUS
    BAPTISTA, T
    HERNANDEZ, L
    HOEBEL, BG
    [J]. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1990, 37 (02) : 227 - 229
  • [4] Antipsychotic drugs and obesity:: Is prolactin involved?
    Baptista, T
    Lacruz, A
    Meza, T
    Contreras, Q
    Delgado, C
    Mejìas, MA
    Hernàndez, L
    [J]. CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2001, 46 (09): : 829 - 834
  • [5] EFFECTS OF LONG-TERM ADMINISTRATION OF CLOZAPINE ON BODY-WEIGHT AND FOOD-INTAKE IN RATS
    BAPTISTA, T
    MATA, A
    TENEUD, L
    DEQUIJADA, M
    HAN, HW
    HERNANDEZ, L
    [J]. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1993, 45 (01) : 51 - 54
  • [6] Endocrine and metabolic abnormalities involved in obesity associated with typical antipsychotic drug administration
    Baptista, T
    Lacruz, A
    Angeles, F
    Silvera, R
    de Mendoza, S
    Mendoza, MT
    Hernández, L
    [J]. PHARMACOPSYCHIATRY, 2001, 34 (06) : 223 - 231
  • [7] Glucose tolerance and serum insulin levels in an animal model of obesity induced by sub-acute or chronic administration of antipsychotic drugs
    Baptista, T
    Alvarez, L
    Lacruz, A
    De Mendoza, S
    Hernández, L
    [J]. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 1999, 23 (02) : 277 - 287
  • [8] Mechanism of the neuroleptic-induced obesity in female rats
    Baptista, T
    Contreras, Q
    Teneud, L
    Albornoz, MA
    Acosta, A
    Paez, X
    de Quijada, M
    Lacruz, A
    Hernandez, L
    [J]. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 1998, 22 (01) : 187 - 198
  • [9] PUBERTY MODIFIES SULPIRIDE EFFECTS ON BODY-WEIGHT IN RATS
    BAPTISTA, T
    PARADA, MA
    MURZI, E
    [J]. NEUROSCIENCE LETTERS, 1988, 92 (02) : 161 - 164
  • [10] Tamoxifen prevents sulpiride-induced weight gain in female rats
    Baptista, T
    DeBaptista, EA
    Hernandez, L
    Altemus, M
    Weiss, SR
    [J]. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1997, 57 (1-2) : 215 - 222